NEW

Health Affairs recently published a report on the way state insurance departments can help with making the data from the…

Prescription drug prices have been a hot topic for years, and while Congress has held hearings and passed legislation in an…

Recently, a bipartisan group of United States Senators sent a letter to the Internal Revenue Service (IRS) and the Treasury…

Recently, the American Telemedicine Association (ATA) Action submitted comprehensive recommendations to the United States Drug…

The world of hematology is constantly evolving, with breakthroughs and advancements that are improving the lives of patients…

Recently, Health Affairs posted a research article, “CMS Hospital Value-Based Programs: Refinements Are Needed to Reduce Health…

On August 21, 2023, the Centers for Medicare & Medicaid Services (CMS) released draft guidance on a new program that will…

Medicare will negotiate the prices of top-selling drugs for blood clots, diabetes, cancer and arthritis, flexing newly granted…

On August 11, 2023, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued an…

This summer, the United States Centers for Medicare and Medicaid Services (CMS) issued multiple civil monetary penalty (CMP)…